Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma

被引：0
|
作者：
Zongqiang Hu
Gang Chen
Yingpeng Zhao
Hongqiang Gao
Laibang Li
Yanfeng Yin
Jie Jiang
Li Wang
Yuanyi Mang
Yang Gao
Shengning Zhang
Jianghua Ran
Li Li
机构：
[1] First People’s Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University,Department of Hepato
来源：
Molecular Cancer | / 22卷 / 1期
关键词：
circRNA; CCAR1; Hepatocellular carcinoma; Exosome; Anti-PD1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
    Hu, Zongqiang
    Chen, Gang
    Zhao, Yingpeng
    Gao, Hongqiang
    Li, Laibang
    Yin, Yanfeng
    Jiang, Jie
    Wang, Li
    Mang, Yuanyi
    Gao, Yang
    Zhang, Shengning
    Ran, Jianghua
    Li, Li
    MOLECULAR CANCER, 2023, 22 (01)
  • [2] Anti-PD1 therapy and CD8 T cell invigoration in metastatic melanoma
    Huang, Alexander
    Xu, Wei
    Harmon, Shannon
    Quagliarello, Felix
    Herati, Ramin
    Pauken, Kristen
    Bengsch, Bertram
    Schuchter, Lynn
    Amaravadi, Ravi
    McGettigan, Suzanne
    Gangadhar, Tara
    Wherry, John
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [3] Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8+ T-cell infiltration in hepatocellular carcinoma
    Song, Fei
    Hu, Bo
    Liang, Xiao-Liang
    Cheng, Jian-Wen
    Wang, Cheng-Gui
    Wang, Peng-Xiang
    Wang, Tian-Lun
    Tang, Peng-Ju
    Sun, Hai-Xiang
    Guo, Wei
    Zhou, Jian
    Fan, Jia
    Chen, Zhong
    Yang, Xin-Rong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (08):
  • [4] Identification of PD-L1-expressing exosome-derived microRNAs in human hepatocellular carcinoma
    Lee, Yu Rim
    Seo, Jae Kyoung
    Kim, Gyeonghwa
    Jang, Se Young
    Park, Soo Young
    Tak, Won Young
    Kweon, Young Oh
    Park, Jung Gil
    Kang, Min Kyu
    Lee, Hye Won
    Hur, Keun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S633 - S634
  • [5] Exosome-derived circTRPS1 promotes malignant phenotype and CD8+T cell exhaustion in bladder cancer microenvironments
    Yang, Chen
    Wu, Siqi
    Mou, Zezhong
    Zhou, Quan
    Dai, Xiyu
    Ou, Yuxi
    Chen, Xinan
    Chen, Yiling
    Xu, Chenyang
    Hu, Yun
    Zhang, Limin
    Zou, Lujia
    Jin, Shengming
    Hu, Jimeng
    Mao, Shanhua
    Jiang, Haowen
    MOLECULAR THERAPY, 2022, 30 (03) : 1054 - 1070
  • [6] PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
    Shi, Feng
    Shi, Ming
    Zeng, Zhen
    Qi, Rui-Zhao
    Liu, Zhen-Wen
    Zhang, Ji-Yuan
    Yang, Yong-Ping
    Tien, Po
    Wang, Fu-Sheng
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (04) : 887 - 896
  • [7] A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1
    Ngiow, Shin Foong
    Young, Arabella
    Jacquelot, Nicolas
    Yamazaki, Takahiro
    Enot, David
    Zitvogel, Laurence
    Smyth, Mark J.
    CANCER RESEARCH, 2015, 75 (18) : 3800 - 3811
  • [8] Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1
    Tyler R. McCaw
    Mei Li
    Dmytro Starenki
    Mingyong Liu
    Sara J. Cooper
    Rebecca C. Arend
    Andres Forero
    Donald J. Buchsbaum
    Troy D. Randall
    Cancer Immunology, Immunotherapy, 2019, 68 : 2081 - 2094
  • [9] Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1
    McCaw, Tyler R.
    Li, Mei
    Starenki, Dmytro
    Liu, Mingyong
    Cooper, Sara J.
    Arend, Rebecca C.
    Forero, Andres
    Buchsbaum, Donald J.
    Randall, Troy D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (12) : 2081 - 2094
  • [10] CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy
    Ando, Satomi
    Araki, Koichi
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (11) : 571 - 577
12345